Literature DB >> 32763396

Convergent click synthesis of macromolecular dendritic β-cyclodextrin derivatives as non-conventional drug carriers: Albendazole as guest model.

Luis José López-Méndez1, Eva Edith Cuéllar-Ramírez1, Neyra Citlali Cabrera-Quiñones1, Yareli Rojas-Aguirre1, Patricia Guadarrama2.   

Abstract

From a materials science perspective, herein we present the design and synthesis of six macromolecular carbohydrate derivatives, obtained by combining the native cyclic oligosaccharide βCD and dendritic poly(ester) moieties, coupled by CuAAc click reactions, in a convergent fashion. We envisioned two structural variables to promote the formation of inclusion complexes (ICs) with the anti-parasitic drug Albendazole, the degree of substitution on the βCD (mono or hepta-substitution) and the dendritic generation (from first to third). In terms of synthetic effort and cost, the mono-substituted βCD derivatives were obtained in more approachable experimental conditions in comparison to the βCD dendrimers (hepta-substituted macrocycle). The six dendritic derivatives were more soluble in water and showed better complexation capacity than native βCD. For both, mono and hepta-substituted βCD, we observed that the amount of encapsulated ABZ increases when the dendron generation increases. Interestingly, different degrees of substitution (mono and hepta) lead comparable results of ABZ complexation. In conclusion, the encapsulation performance and the consequent solubility enhancement, make these molecular containers excellent materials to positively impact the therapeutic desirability of ABZ.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Click chemistry; Cyclodextrin; Dendrimer; Therapeutic desirability

Mesh:

Substances:

Year:  2020        PMID: 32763396     DOI: 10.1016/j.ijbiomac.2020.08.018

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  1 in total

1.  β-cyclodextrin dendritic derivatives as permeation mediators to enhance the in vitro albendazole cysticidal activity by the improvement of the diffusion component.

Authors:  Luis José López-Méndez; Francisca Palomares-Alonso; Iliana González-Hernández; Helgi Jung-Cook; Neyra Citlali Cabrera-Quiñones; Patricia Guadarrama
Journal:  RSC Adv       Date:  2022-08-17       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.